Transfusion and Apheresis Science
Volume 42, Issue 2 , Pages 169-175 , April 2010

Status of hematopoietic stem cell transplantation in the WHO Eastern Mediterranean Region (EMRO)

  • Mahmoud Aljurf

      Affiliations

    • King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    • Corresponding Author InformationCorresponding author. Address: Adult HSCT Program, King Faisal Cancer Center (MBC 64), King Faisal Specialist Hospital and Research Centre, P.O. Box 3354, Riyadh 11211, Saudi Arabia. Tel.: +966 1 442 4586; fax: +966 1 442 3941.
    • ,
  • Syed Z. Zaidi

      Affiliations

    • Prince Sultan Hematology Oncology Center, King Fahad Medical City, Riyadh, Saudi Arabia
    • ,
  • Fazal Hussain

      Affiliations

    • King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    • ,
  • Ardeshir Ghavamzadeh

      Affiliations

    • Hematology–Oncology and SCT Research Center, University of Medical Sciences, Tehran, Iran
    • ,
  • Kamran Alimoghaddam

      Affiliations

    • Hematology–Oncology and SCT Research Center, University of Medical Sciences, Tehran, Iran
    • ,
  • Mohamad Jahani

      Affiliations

    • Hematology–Oncology and SCT Research Center, University of Medical Sciences, Tehran, Iran
    • ,
  • Hossam Kamel Mahmoud

      Affiliations

    • BMT Unit, National Cancer Institute, Cairo University, Egypt
    • ,
  • Ala’a Haddad

      Affiliations

    • BMT Unit, National Cancer Institute, Cairo University, Egypt
    • ,
  • Salman Adil

      Affiliations

    • Agha Khan University Hospital, Karachi, Pakistan
    • ,
  • Tarek Ben Othman

      Affiliations

    • Centre National de Greffe de Moelle Osseuse de Tunis, Tunisia
    • The Centre National de Transfusion Sanguine de Tunis, Tunisia
    • ,
  • Mahmoud M. Sarhan

      Affiliations

    • Bone Marrow and Stem Cell Transplantation Program, King Hussein Cancer Center, Amman, Jordan
    • ,
  • David Dennison

      Affiliations

    • Sultan Qaboos University Hospital, Oman
    • ,
  • Ahmad Ibrahim

      Affiliations

    • Makassed General Hospital, Beirut, Lebanon
    • ,
  • Said Benchekroun

      Affiliations

    • Service d’Hématologie et Oncologie Pédiatrique, Children’s Hospital, Casablanca, Morocco
    • ,
  • Mouhab Ayas

      Affiliations

    • King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    • ,
  • Hazzaa Al Zahrani

      Affiliations

    • King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    • ,
  • Fahad Al Mohareb

      Affiliations

    • King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
    • ,
  • Hassan El Solh

      Affiliations

    • King Faisal Cancer Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

References 

  1. Countries in the WHO Eastern Mediterranean Region shown on http://www.who.int/about/regions/emro/en/index.html (accessed 12.09.08).
  2. Shamsi T, Hashmi K, Irfan M, et al. The stem cell transplant program in Pakistan—the first decade. Bone Marrow Transplant. 2008;42:S114–S117
  3. Othman TB, Torjemane L, Abdelkefi A, et al. Allogeneic stem cell transplantation in Tunisia. Bone Marrow Transplant. 2008;42:S139–S141
  4. Mahmoud HK, El-Haddad AM, Fahmy OA, et al. Hematopoietic stem cell transplantation in Egypt. Bone Marrow Transplant. 2008;42:S76–S80
  5. Aljurf MD, Zaidi SZ, El Solh H, Hussain F, Ghavamzadeh A, Mahmoud HK, et al. A Gratwohl Special issues related to hematopoietic SCT in the Eastern Mediterranean Region and the first regional activity report. Bone Marrow Transplant doi:10.1038/bmt.2008.389 (01 December 2008).
  6. Abdel-Rahman F, Hussein AA, Rihani R, Hlalah OA, et al. Bone marrow and stem cell transplantation at King Hussein Cancer Center (KHCC), Amman-Jordan. Bone Marrow Transplant. 2008;42:S89–S91
  7. Dennison D, Al Kindi S, Pathare A, et al. Hematopoietic stem cell transplantation in Oman. Bone Marrow Transplant. 2008;42:S109–S113
  8. Bazarbachi A, Hatoum HA, Mugharbel A, et al. Hematopoietic stem cell transplantation in Lebanon: first comprehensive report. Bone Marrow Transplant. 2008;42:S96–S102
  9. Benchekroun S, Harif M, Madani A, Quessar A, Zafad S, Rachid R. Present and future of hematology and stem cell transplantation in Morocco. Bone Marrow Transplant. 2008;42:S106–S108
  10. Sheth KV, Elkhalifa M, Kelly T, Sahovic E. What are the chances of finding related HLA match donors for allogeneic BMT recipients in Saudi Arabia?. Blood. 1996;88(Suppl. 1):265b;[Abstract 3787]
  11. Gyger M, Sahovic E, Al Mohareb F, et al. A prospective randomized trial of marrow versus mobilized peripheral blood in HLA-matched related allogeneic transplants using a three-day short course methotrexate and cyclosporin as prophylaxis for acute graft versus host disease. Bone Marrow Transplant 2002;29(Suppl. 2):677 [Abstract 84].
  12. Al Beihany A, Sahovic E, Chaudhri N, et al. Leukemia relapse after allogeneic bone marrow transplantation—how does chronic GVHD influence the pattern and onset of relapse? Bone Marrow Transplant 2005;35(Suppl. 2):S135 [Abstract 536].
  13. Stem Cell Trialists’ Collaborative Group. Individual patient data met-analysis of allogeneic peripheral blood stem cell transplant vs bone marrow transplant in the management of hematological malignancies: indirect assessment of the effect of day 11 methotrexate administration. Bone Marrow Transplant 2006;38:539–46.
  14. Stem Cell Trialists’ Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient care data meta-analysis of nine randomized trials. J Clin Oncol 2005;23:5074–87.
  15. Oh H, Loberiza FR, Zhang MJ, et al. Comparison of graft-versus-host disease and survival after HLA-identical sibling bone marrow transplantation in ethnic population. Blood. 2005;105:1408–1416
  16. Bu R, Gutierrez MI, Al-Rasheed M, Belgaumi A, Bhatia K. Variable drug metabolism genes in Arab population. Pharmacogenom J. 2004;4:260–266
  17. Brown KE, Tisdale J, Barrett AJ, Dunbar CE, Young NS. Hepatitis-associated aplastic anemia. N Engl J Med. 1997;336:1059–1064
  18. Hibbs JR, Frickhofen N, Rosenfeld SJ, et al. Aplastic anemia and viral hepatitis non-A, non-B, non-C?. JAMA. 1992;267:2051–2054
  19. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR–ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med. 2001;344:1031–1037
  20. Marcucci G, Mrózek K, Ruppert AS, et al. Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. J Clin Oncol. 2005;23:5705–5717
  21. Sahovic E, Al-Suliman A, Aslam M, et al. Successful Prevention of CMV Disease after Allogeneic BMT in 100 Consecutive CMV Seropositive Recipients. Blood 1999;94(10) [Abstract 4888].
  22. Boeckh M, Bowden RA, Gooley T, Myerson D, Corey L. Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipients. Blood. 1999;93:1781
  23. Al-Faleh FZ. Hepatitis B infection in Saudi Arabia. Ann Saudi Med. 1988;8:474–480
  24. Ashraf AryaSC, Parande CM SJ, et al. Hepatitis B virus in Gizan. Saudi Arabia. J Med Virol. 1985;17:267–274
  25. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine. 2000;18(Suppl. 1):S20–S22
  26. Seth P, Alrajhi AA, Kagevi I, et al. Hepatitis B virus reactivation with clinical flare in allogeneic stem cell transplants with chronic graft-versus-host disease. Bone Marrow Transplant. 2002;30:189–194
  27. Saeed AA, Al-Admawi AM, Al-Rasheed A, et al. Hepatitis C virus in Egyptian blood donors in Riyadh. Lancet. 1991;33:359–360
  28. El-Hazmi MM. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. Saudi Med J. 2004;25(1):26–33
  29. Mahaba H, Ael-K El-Tayeb, Elbaz H. The prevalence of antibodies to hepatitis C virus in Hail region, Saudi Arabia. J Egypt Public Health Assoc. 1999;74(1–2):69–80
  30. El Guneid AM, Gunaid AA, O’Neill AM, Zureikat NI, Coleman JC, Murray-Lyon IM, et al. C and D virus markers in Yemeni patients with chronic liver disease. J Med Virol. 1993;40:330–333
  31. Al-Ahdal MN, Rezeig MA, Kessie G. Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from pcr-amplified core region of the virus genome. Ann Saudi Med. 1997;17(6):601–604
  32. Osoba AO. Hepatitis C virus genotypes in Saudi Arabia. Saudi Med J. 2002;23:7–12
  33. Bdour S. Hepatitis C virus infection in Jordanian haemodialysis units, serological diagnosis and genotyping. J Med Microbiol. 2002;51:700–704
  34. Shobokshi OA, Serebour FE, Skakni L, Al Safy YH, Ahdal MN. Hepatitis C genotypes and subtypes in Saudi Arabia. J Med Virol. 1999;58:44–48
  35. Kabir A, Alavian S, Keyvani H. Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study. Comparative Hepatology 2006;5:4 doi:10.1186/1476-5926-5-4.
  36. Aljurf M, Gyger M, Alrajhi A, Sahovic E, et al. Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients. Bone Marrow Transplant. 1999;24:551–554
  37. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients; recommendations of the CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2000;6:659–734.
  38. Mahmoud HK. Schistosomiasis as a predisposing factor to veno-occlusive disease of the liver following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1996;17(3):401–403
  39. Roll Back Malaria Monitoring and Evaluation in Pakistan – WHO report <http://www.rbm.who.int/wmr2005/profiles/paquistan.pdf>.
  40. Gratwohl A, Baldomero H, Horisberger B, Schmid C, Passweg J, Urbano-Ispizua A. Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Current trends in haematopoietic stem cell transplantation in Europe. Blood. 2002;100:2374–2386
  41. Gratwohl A, Baldomero H, Frauendorfer K, Urbano-Ispizua A. Accreditation Committee, International Society for Cellular Therapy; European Group for Blood and Marrow Transplantation; EBMT activity survey 2004 and changes in disease indication over the past 15 years. Bone Marrow Transplant. 2006;37(12):1069–1085
  42. Gratwohl A, Baldomero H, Frauendorfer K, Niederwieser D. Why are there regional differences in stem cell transplantation activity? An EBMT analysis. Bone Marrow Transplant. 2008;42:S7–S10
  43. Gratwohl A, Baldomero H, Frauendorfer K, Gratwohl M. Apperley 1. Niederwieser D predictability of hematopoietic stem cell transplantation rates. Haematologica. 2007;92(12):1679–1686
  44. Gratwohl A, Baldomero H, Passweg J, et al. A. for the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT) in cooperation with the Working Parties Acute (ALWP) and Chronic Leukemias (CLWP) and the Lymphoma Working Party Hematopoietic stem cell transplantation for hematological malignancies in Europe. Leukemia. 2003;17:941–959
  45. Gratwohl A, Passweg J, Baldomero H, Horisberger B, Urbano-Ispizua A. For the Accreditation Committee of the European Group for Blood and Marrow Transplantation (EBMT). Economics, health care systems and utilization of hematopoietic stem cell transplants in Europe. Br J Haemtol. 2002;117:451–468

PII: S1473-0502(10)00013-3

doi: 10.1016/j.transci.2010.01.012

Transfusion and Apheresis Science
Volume 42, Issue 2 , Pages 169-175 , April 2010

Article Tools